White hybrid light‐emitting diodes (WHLEDs) are considered as a solid approach toward environmentally sustainable lighting sources that meet the “Green Photonics” requirements. Here, WHLEDs with protein‐based down‐converting coatings, i.e., Bio‐WHLEDs, are demonstrated and exhibit worthy white color quality, luminous efficiency, and stability values. The coatings feature a multilayered cascade‐like architecture with thicknesses of 1–3 mm. This limits the efficiency due to the low optical transmittance. Thus, submillimeter coatings, where the location of the proteins is well‐defined, are highly desired. It is in this context where the thrust of this work sets in. Here, a straightforward way to design microstructured single‐layer coatings, in which the proteins are placed at our command by using 3D printing, is presented. Based on comprehensive spectroscopic and rheological investigations, the optimization of the matrix and the plotting to prepare different micropatterns, i.e., lines, open‐grids, and closed‐grids, is rationalized. The latter are applied to prepare Bio‐WHLEDs with ≈5‐fold enhancement of the luminous efficiency compared to the reference devices with a cascade‐like coating, without losing stability and color quality. As such, this work shows a new route to exploit proteins for optoelectronics, setting a new avenue of research into the emerging field of Bio‐WHLEDs.

This study demonstrated fewer acute rejections in transplants with more HLA compatibilities. However, in liver transplantation, a more specific investigation of HLA typing may be necessary, because in some indications HLA antigens play a role in the nature of the disease. Therefore, recurrence of autoimmune disease may be more severe in patients sharing HLA antigens.

Bio-hybrid light-emitting diodes (Bio-HLEDs) based on color down-converting filters with fluorescent proteins (FPs) have achieved moderate efficiencies (50 lm/W) and stabilities (300 h) due to both thermal-and photo-degradation. Here, we present a significant enhancement in efficiency (~130 lm/W) and stability (>150 days) using a zero-thermalquenching bio-phosphor design. This is achieved shielding the FP surface with a hydrophilic polymer allowing their homogenous integration into the network of a light-guiding and hydrophobic host polymer. We rationalize how the control of the mechanical and optical features of this bio-phosphor is paramount towards highly stable and efficient Bio-HLEDs, regardless of the operation conditions. This is validated by the relationships between the stiffness of the FP-polymer phosphor and the maximum temperature reached under device operation as well as the transmittance of the filters and device efficiency.

Life threatening pneumonias after liver transplantation are often caused by opportunistic pathogens such as Legionella pneumophila, Pneumocystis carinii, Aspergillus species and cytomegalovirus (CMV). Due to the high incidence of morbidity and mortality caused by these pneumonias we reviewed 700 liver transplants for risk factors for the development of opportunistic pneumonia. Immunosuppression was commenced as either cyclosporin A- or tacrolimus-based protocols. In a subgroup of patients, splenectomy was performed simultaneously with liver transplantation ( n=57). Overall 60 opportunistic pneumonias occurred in 700 liver transplants. Using a stepwise logistic regression analysis, we found that OKT3 treatment and simultaneous splenectomy revealed a significantly increased risk for opportunistic pneumonia. Our study identified splenectomy as a major risk factor for the development of opportunistic pneumonia after liver transplantation. In these patients prophylactic protocols and early diagnosis may improve the long-term outcome.